S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
66,000% upside on tiny biotech? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
66,000% upside on tiny biotech? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
66,000% upside on tiny biotech? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
66,000% upside on tiny biotech? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
NASDAQ:HSIC

Henry Schein (HSIC) Price Target & Analyst Ratings

$74.42
+0.99 (+1.35%)
(As of 06/2/2023 ET)
Compare
Today's Range
$73.50
$74.67
50-Day Range
$73.43
$85.22
52-Week Range
$64.75
$89.72
Volume
773,706 shs
Average Volume
905,685 shs
Market Capitalization
$9.75 billion
P/E Ratio
21.26
Dividend Yield
N/A
Price Target
$85.67

Henry Schein Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 8 Analyst Ratings

Consensus Analyst Price Target

$85.67
15.11% Upside
High Prediction$97.00
Average Prediction$85.67
Low Prediction$69.00
TypeCurrent
6/4/22 to 6/4/23
1 Month Ago
5/5/22 to 5/5/23
3 Months Ago
3/6/22 to 3/6/23
1 Year Ago
6/4/21 to 6/4/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$85.67$85.89$85.67$94.40
Predicted Upside15.11% Upside7.29% Upside7.54% Upside17.37% Upside
Get Henry Schein Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.


HSIC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HSIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Henry Schein Stock vs. The Competition

TypeHenry ScheinMedical CompaniesS&P 500
Consensus Rating Score
2.25
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside15.11% Upside1,263.10% Upside209.75% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/10/2023Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$92.00 ➝ $90.00+19.28%
3/7/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$75.00 ➝ $82.00+4.38%
2/28/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$99.00 ➝ $97.00+23.79%
2/21/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight$70.00 ➝ $69.00-16.29%
2/6/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$85.00 ➝ $97.00+11.82%
11/1/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
8/9/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$83.00+8.88%
7/21/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$93.00 ➝ $85.00+8.97%
6/17/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$90.00 ➝ $80.00+9.33%
6/14/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$103.00 ➝ $88.00+11.65%
(Data available from 6/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












HSIC Price Target - Frequently Asked Questions

What is Henry Schein's consensus rating and price target?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Henry Schein stock is Hold based on the current 1 sell rating, 4 hold ratings and 3 buy ratings for HSIC. The average twelve-month price prediction for Henry Schein is $85.67 with a high price target of $97.00 and a low price target of $69.00. Learn more on HSIC's analyst rating history.

Do Wall Street analysts like Henry Schein more than its competitors?

Analysts like Henry Schein less than other Medical companies. The consensus rating for Henry Schein is Hold while the average consensus rating for medical companies is Buy. Learn more on how HSIC compares to other companies.

Does Henry Schein's stock price have much upside?

According to analysts, Henry Schein's stock has a predicted upside of 7.63% based on their 12-month price targets.

What analysts cover Henry Schein?

Henry Schein has been rated by Barrington Research, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:HSIC) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -